2025年1月31日 · Hepatitis A vaccine series are typically administered over the course of 6 months. Hepatitis A vaccines are safe and highly effective. CDC recommends that the following groups be vaccinated against hepatitis A: Children. All children ages 12-23 months. Unvaccinated children and adolescents age 2-18 years.

HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization...

series (2-dose series Heplisav-B at least 4 weeks apart [2-dose series HepB only applies when 2 doses of Heplisav-B are used at least 4 weeks apart] or 3-dose

HAVRIX (hepatitis A vaccine, inactivated) is indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 …

2024年5月21日 · Both vaccines are approved as a 2-dose series. The second dose of Vaqta is administered 6 through 18 months after the first dose, and the second dose of Havrix is administered 6 through 12 months after the first dose. HepA-HepB (Twinrix) is licensed for persons age 18 years or older and administered as a 3-dose series at 0, 1, and 6 months.

2024年6月12日 · Havrix: 1 mL IM followed by a 1 mL booster dose 6 to 12 months following primary immunization. Primary immunization is recommended at least 2 weeks before expected exposure to hepatitis A virus. Immune globulin may be administered with the vaccine (at a different injection site) to patients requiring immediate prophylaxis or postexposure ...

2025年1月8日 · HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV. (1) 0.5-mL single-dose prefilled syringes. (3) 1-mL single-dose prefilled syringes.

Routine series for Indigenous infants: C, D. 2 doses given as 0.5 mL of HAVRIX® 720 Junior (720 ELU) IM . at 6 and 18 months of age. Other eligible individuals: 6 months-18 years of age (inclusive): D. 2 doses given as 0.5 mL of HAVRIX® 720 Junior (720 ELU) IM, separated by 6 months. 19 years of age and older: D. 2 doses given as 1.0 mL of ...

2-dose vaccination series. ≥19 years: 1 mL IM (primary dose) Administer primary dose at least 2 weeks before expected exposure to HAV; Havrix: Administer booster dose 6-12 mo after...

Dose 1: day 0 Dose 2: 6 to 12 months after dose 1 . Notes: • If the second dose in the hepatitis A vaccine series is missed, it can be administered at a later time without repeating the first dose. • Infant candidates or recipients of SOT. See Immunization for Children Expecting Solid Organ Transplant before 18 months.